IV Versus Subcutaneous Enoxaparin in Critically Ill Infants and Children-Reference-Cited by-同舟云学术

IV Versus Subcutaneous Enoxaparin in Critically Ill Infants and Children

Published:2017-05 Issue:5 Volume:18 Page:e207-e214
ISSN:1529-7535
Container-title:Pediatric Critical Care Medicine
language:en
Short-container-title:Pediatric Critical Care Medicine

Author:

Diab Yaser A.,Ramakrishnan Karthik,Ferrell Brandon,Chounoune Reginald,Alfares Fahad A.,Endicott Kendal M.,Rooney Sara,Corcoran Jason,Zurakowski David,Berger John T.,Shankar Venkat,Nath Dilip S.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine,Pediatrics, Perinatology and Child Health

Reference25 articles.

1. Incidence and Risk Factors for Venous Thromboembolism in Critically Ill Children With Cardiac Disease

2. Incidence and risk factors associated with venous thrombotic events in pediatric intensive care unit patients*

3. Current treatment practices of venous thromboembolism in children admitted to pediatric intensive care units

4. Pharmacodynamic and Pharmacokinetic Properties of Enoxaparin

5. Population pharmacokinetics of enoxaparin in infants, children and adolescents during secondary thromboembolic prophylaxis: a cohort study

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Impact of a Standardized Risk-Stratified Thromboprophylaxis Protocol for Multisystem Inflammatory Syndrome in Children;The Journal of Pediatrics;2023-11

2. Questions around a case ofin uterothrombosis in a premature child, concerning the management of anticoagulant treatments;European Journal of Hospital Pharmacy;2023-09-29

3. Retrospective Evaluation of Intravenous Enoxaparin Administration in Feline Arterial Thromboembolism;Animals;2022-08-04

4. Effect of targeted individualized nutrition support on patients with severe diseases during hospitalization;Food Science and Technology;2021-10-24

5. Anti-Xa levels in critically ill children receiving enoxaparin for venothromboembolism prophylaxis;Thrombosis Research;2021-07